Open official notice

VerifyNow P2Y12 Platelet Reactivity Test, REF: 85064

Official notice

22 Jan 2025

RecallScope risk estimate:MediumFDA

An official FDA notice concerns VerifyNow P2Y12 Platelet Reactivity Test, REF: 85064. Platelet Reactivity Test distributed without appropriate US-FDA market clearance; if used healthcare personnel could use the baseline PRUTest measurement prior to initiating drug therapy, and then use the percent inhibition formula in the notice to manually calculate the percentage of platelet aggregation inhibition for a given patient receiving drug treatment with P2Y12 receptor inhibitor. Published 2025-01-22.

What to do now

Stop using the affected device and follow the corrective action in the official FDA notice. Contact your healthcare provider or the manufacturer for next steps.

Units affected

25

Recall number

Z-0961-2025

Official notice

2025-01-22

The hazard

Platelet Reactivity Test distributed without appropriate US-FDA market clearance; if used healthcare personnel could use the baseline PRUTest measurement prior to initiating drug therapy, and then use the percent inhibition formula in the notice to manually calculate the percentage of platelet aggregation inhibition for a given patient receiving drug treatment with P2Y12 receptor inhibitor.

How to check if you’re affected

Compare the product name and identifiers below with the item you own. Check the official notice for the affected products and next steps.

Other

UDI-DI 10711234150054

Event Ids

96011

Recall Numbers

Z-0961-2025

Checked manually this time?

Follow brands and keywords in the app to receive alerts for matching official notices.

Turn on recall alerts

Affected products

Product 1

VerifyNow P2Y12 Platelet Reactivity Test, REF: 85064

Units affected

25

Hazard

Platelet Reactivity Test distributed without appropriate US-FDA market clearance; if used healthcare personnel could use the baseline PRUTest measurement prior to initiating drug therapy, and then use the percent inhibition formula in the notice to manually calculate the percentage of platelet aggregation inhibition for a given patient receiving drug treatment with P2Y12 receptor inhibitor.

Where it was sold

Retailer information is not currently available in RecallScope. Check the official notice for distribution details.

Location 1

US · United States

Affected area 1

US · United States

Company & contacts

Manufacturer

Accriva Diagnostics, Inc.

Phone

Not provided

Brand: Accriva Diagnostics. Contact: Accriva Diagnostics, Inc..

Source & status

Source

Tier

official

Category

Tech & Electronics

Official classification

Class II

Recall details

Recall number

Z-0961-2025

Event ID

96011

Units affected

25

Status

active

Source tier

official

Documents, notices & source

See the official notice and source documents for full details.

View full official notice
Something wrong on this page?

Weekly recall digest

Get next week’s recalls before you need them.

One email every Monday with official-source recalls for your country, and nothing else. Unsubscribe from any email.

The digest arrives once a week. For matching recall alerts after notices are processed, get the app.

This recall was published 22 Jan 2025. The next one won’t wait for you to search.

RecallScope checks listed publishers for the brands and VINs you follow, and can alert you when a matching notice is processed.

apple-buttongoogle-button